Actavis Holdco Says FTC's AndroGel Antitrust Suit Is Moot
Newly acquired Teva subsidiary Actavis Holdco asked a Georgia federal court Friday to end claims against it in an FTC lawsuit alleging pharmaceutical companies illegally conspired to delay generic competition for...To view the full article, register now.
Already a subscriber? Click here to view full article